comprehensive
Previous article:
Medical leaders decry Supreme Court decision on affirmative action
Next article: Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee
Next article: Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee
hotspot
focus
-
Readout Newsletter: The latest on Moderna, Apellis, and Merck
2025-09-30 00:03 -
In Spain, a hospital brews its own CAR
2025-09-29 23:25 -
Why health records don't always know when patients are dead
2025-09-29 23:13 -
Why Talkspace is targeting Medicare, a tricky market
2025-09-29 22:41 -
State of the Union pitch: Bigger Medicare drug price negotiations
2025-09-29 22:07 -
Editas, Vertex strike deal on CRISPR
2025-09-29 21:58